O. Marano

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer

M. Caraglia, G. Colucci, G. Nasti, 2005, British Journal of Cancer.

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer

M. Caraglia, G. Colucci, G. Nasti, 2005, British Journal of Cancer.

Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer.

R. Autorino, G. Tortora, A. Bianco, 2004, European urology.

Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer

M. Caraglia, G. Colucci, G. Nasti, 2005, British Journal of Cancer.

Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety

F. Ciardiello, R. Addeo, F. Nuzzo, 2018, Molecular and clinical oncology.